European panel supports Genzyme's Myozyme facility

02/20/2009 | Boston Globe (tiered subscription model), The

A committee of the European Commission issued a positive opinion regarding Genzyme's application to produce and market Pompe disease drug Myozyme at a Belgian manufacturing plant. The European Commission will make a final decision based on the opinion of the Committee for Medicinal Products for Human Use.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care